We are live on ! Find out more
EXEL icon

Exelixis

415 hedge funds and large institutions have $5.47B invested in Exelixis in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 141 increasing their positions, 173 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $62.5M | Put options by funds: $31M

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

0% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 42

0.08% less ownership

Funds ownership: 83.64%83.56% (-0.08%)

2% less funds holding

Funds holding: 422415 (-7)

9% less capital invested

Capital invested by funds: $6.02B → $5.47B (-$546M)

18% less repeat investments, than reductions

Existing positions increased: 141 | Existing positions reduced: 173

Holders
415
Holders Change
-7
Holders Change %
-1.66%
% of All Funds
5.98%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
42
Increased
141
Reduced
173
Closed
42
Calls
$62.5M
Puts
$31M
Net Calls
+$31.4M
Net Calls Change
+$11.1M

EXEL Hedge Fund Activity: Q2 2024 in Review

415 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2024, worth a combined $5.47B — down 9.1% from $6.02B a quarter earlier.

Fund positioning in EXEL was balanced in Q2 2024: 42 funds opened new positions, 42 closed out, 141 added to existing stakes and 173 trimmed.

The largest buyer was LSV Asset Management, adding an estimated $66.3M. The largest seller was Morgan Stanley, cutting an estimated $53.5M.

  • 415 institutional investors held Exelixis (EXEL) as of Q2 2024, down from 422 in Q1 2024.
  • Funds reported $5.47B of Exelixis stock for Q2 2024, down 9.1% quarter-over-quarter.
  • 42 funds opened new Exelixis positions in Q2 2024 and 42 closed out, a net change of 0 holders.
  • The largest Exelixis buyer in Q2 2024 was LSV Asset Management, an estimated $66.3M added.
  • The largest Exelixis seller in Q2 2024 was Morgan Stanley, an estimated $53.5M sold.

Based on aggregated 13F filings for Q2 2024.